QIAGEN N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.68 USD | +0.04% |
|
-0.35% | +2.03% |
| Sep. 18 | QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform | CI |
| Sep. 13 | Qiagen, Bio-Manguinhos/Fiocruz Launch Malaria Detection Test in Brazil | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 10.15B | ||||||
| 46.01B | ||||||
| 43.75B | ||||||
| 35.24B | - | |||||
| 30.44B | ||||||
| 27.67B | - |
- Stock Market
- Equities
- QGEN Stock
- Charts Qiagen N.V.
- Sector Chart